Delcath Systems (FRA:DV3R) Accounts Payable & Accrued Expense : €3.97 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems Accounts Payable & Accrued Expense?

Delcath Systems's quarterly accounts payable & accrued expense declined from Sep. 2023 (€4.17 Mil) to Dec. 2023 (€4.04 Mil) and declined from Dec. 2023 (€4.04 Mil) to Mar. 2024 (€3.97 Mil).

Delcath Systems's annual accounts payable & accrued expense increased from Dec. 2021 (€2.07 Mil) to Dec. 2022 (€5.35 Mil) but then declined from Dec. 2022 (€5.35 Mil) to Dec. 2023 (€4.04 Mil).

Delcath Systems Accounts Payable & Accrued Expense Historical Data

The historical data trend for Delcath Systems's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Accounts Payable & Accrued Expense Chart

Delcath Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4.91

2.24

2.07

5.35

4.04

Delcath Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5.22	4.79	4.17	4.04	3.97

Delcath Systems Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Delcath Systems (FRA:DV3R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

DCTH:USA

Address

1633 Broadway, Suite 22C, New York, NY, USA, 10019

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines